Drug intelligence / Profile preview

olea europaea + phleum pratense

Development stage
Unknown
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

olea europaea + phleum pratense is a combination of two allergen extracts derived from *Olea europaea* (olive pollen) and *Phleum pratense* (timothy grass pollen). These allergens are among the most common causes of respiratory allergic diseases, such as allergic rhinitis and allergic asthma, particularly in regions where both olive trees and grasses are prevalent. Combination preparations of these pollen extracts may be used in allergen immunotherapy, aiming to modulate the immune response and reduce symptoms in individuals sensitized to both pollens. The mechanism is believed to involve immune tolerance induction, most likely mediated by regulatory cytokines such as IL-10 and IL-35, reducing IgE-mediated hypersensitivity and inflammatory responses[1][2][3].

Other names
olive pollen + timothy grass pollenolea europaea pollen + phleum pratense pollen

Beyond the preview

Go deeper on olea europaea + phleum pratense.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on olea europaea + phleum pratense.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call